Repurposing a cholesterol drug may benefit DiGeorge syndrome patients with neuropsychiatric disease

Researchers have found that mitochondrial dysfunction in the blood-brain barrier (BBB) may lead to neuropsychiatric disease in some patients with DiGeorge syndrome.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup